Aveeno Baby Lotion Recall Issued Due to Bacteria Levels

About 2,200 tubes of Aveeno lotion for babies have been recalled by Johnson & Johnson, after the FDA detected high amounts of bacteria in one lot of the tubes. 

The Aveeno baby lotion recall was announced on January 27, after FDA testing of a product sample. However, Johnson & Johnson indicates that its own testing has revealed no contamination and there have been no reports of illness or infection connected to the recalled Aveeno lotion.

Johnson & Johnson is only initiating the recall at the retailer level, and is not asking consumers to return the tubes of Aveeno lotion.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Retail-level recalls have become a staple of the drug and health product manufacturer, which has garnered it considerable criticism by some who see it as a ploy to avoid bad publicity. The company was lambasted by the FDA and members of congress last year after hearings into so-called “phantom recalls” where the company paid people to buy drugs off of store shelves instead of announcing a recall and alerting the public to potential manufacturing problems.

Despite the “retail level” designation, Johnson & Johnson has said that consumers can seek a refund on recalled Aveno tubes.

The recall affects one lot of Aveeno Baby Calming Comfort Lotion with lot number 0161LK and UPC Code 38137-0036456. The lot number and UPC code are embossed on the tubes. The recalled lotion was distributed in Alabama, Arkansas, Florida, Georgia, Kansas, Louisiana, Mississippi, Tennessee and Texas.

Consumers with questions about the Aveeno recall, or who wish to receive a refund, can call the Johnson & Johnson Consumer Call Center at 1-877-298-2525.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Ahead of a case management conference this week, hair relaxer cancer lawsuit lawyers have asked a federal judge to set a date for the first bellwether trial.
As Bard PowerPort litigation nears its first bellwether trials, the prospect of major jury verdicts over catheter fracture, migration and infection injuries is increasing speculation that settlement talks may intensify, following earlier claims that Becton Dickinson says were resolved in about 18 months before consolidation into a federal MDL.